Virbac (CHIX:VIRPP) Inventories, Finished Goods: €243 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:VIRPP Virbac SA CHIX:VIRPP
93 GF Score
Price €334.00
GF Value €375.00
! 2 Warning Signs
View Full Analysis

What is Virbac Inventories, Finished Goods?

Virbac CHIX:VIRPP 93 Inventories, Finished Goods is €243 Mil as of Dec. 2025. GuruFocus rates CHIX:VIRPP with a GF Score™ of 93/100 and a GF Value™ of €375.00. The stock has 2 warning signs investors should review.

Virbac's quarterly finished goods declined from Dec. 2024 (€265 Mil) to Jun. 2025 (€254 Mil) and declined from Jun. 2025 (€254 Mil) to Dec. 2025 (€243 Mil).

Virbac's annual finished goods increased from Dec. 2023 (€210 Mil) to Dec. 2024 (€265 Mil) but then declined from Dec. 2024 (€265 Mil) to Dec. 2025 (€243 Mil).

Virbac Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Virbac's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virbac Inventories, Finished Goods Chart

Virbac Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 172.32 203.46 210.46 265.27 242.64

Virbac Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 210.46 258.60 265.27 254.49 242.64
CHIX:VIRPP
93GF Score
Virbac SA CHIX:VIRPP
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Virbac Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of €243 Mil mean?
Virbac (CHIX:VIRPP) has a Inventories, Finished Goods of €243 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Virbac and its competitors.
Is Virbac's Inventories, Finished Goods too high?
Virbac's current Inventories, Finished Goods is €243 Mil. Overall, Virbac has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Virbac's Inventories, Finished Goods compare to LLY and JNJ?
Virbac's Inventories, Finished Goods of €243 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Virbac and its competitors. Virbac's current Inventories, Finished Goods is €243 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virbac stock overvalued right now?
Virbac (CHIX:VIRPP) has a current Inventories, Finished Goods of €243 Mil. The stock's GF Value™ is €375.00, compared to a current price of €334.00 — trading 10.9% below its estimated fair value. The current Inventories, Finished Goods is €243 Mil. Virbac's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Virbac (CHIX:VIRPP), the current Inventories, Finished Goods is €243 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Virbac (CHIX:VIRPP) Overvalued in 2026?

Based on GuruFocus' analysis, Virbac stock appears to be undervalued. The current stock price of €334.00 is trading 10.9% below its estimated GF Value™ of €375.00.

Key valuation signals for CHIX:VIRPP:

  • Inventories, Finished Goods: €243 Mil
  • GF Value™: €375.00 vs. price of €334.00 (10.9% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the CHIX:VIRPP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Virbac Business Description

Address 13e rue, 1ere avenue 2065, LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.
93GF Score

Get the complete analysis for CHIX:VIRPP

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€334.00
Price
€375.00
GF Value